BFS
Bard Financial Services’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Sell |
67,095
-1,125
| -2% | -$209K | 1.49% | 12 |
|
|
2025
Q1 | $14.3M | Sell |
68,220
-910
| -1% | -$191K | 1.75% | 8 |
|
|
2024
Q4 | $12.3M | Sell |
69,130
-125
| -0.2% | -$22.2K | 1.47% | 11 |
|
|
2024
Q3 | $13.7M | Sell |
69,255
-5,500
| -7% | -$1.09M | 1.61% | 11 |
|
|
2024
Q2 | $12.8M | Sell |
74,755
-350
| -0.5% | -$60K | 1.33% | 16 |
|
|
2024
Q1 | $13.7M | Hold |
75,105
| – | – | 1.45% | 12 |
|
|
2023
Q4 | $11.6M | Buy |
75,105
+1,440
| +2% | +$223K | 1.3% | 14 |
|
|
2023
Q3 | $11M | Buy |
73,665
+690
| +0.9% | +$103K | 1.36% | 17 |
|
|
2023
Q2 | $9.83M | Sell |
72,975
-1,000
| -1% | -$135K | 0.74% | 34 |
|
|
2023
Q1 | $11.8M | Sell |
73,975
-250
| -0.3% | -$39.8K | 0.94% | 25 |
|
|
2022
Q4 | $12M | Sell |
74,225
-145
| -0.2% | -$23.4K | 1.02% | 25 |
|
|
2022
Q3 | $9.98M | Sell |
74,370
-250
| -0.3% | -$33.6K | 0.94% | 23 |
|
|
2022
Q2 | $11.4M | Sell |
74,620
-500
| -0.7% | -$76.6K | 1.04% | 23 |
|
|
2022
Q1 | $12.2M | Buy |
75,120
+200
| +0.3% | +$32.4K | 0.99% | 21 |
|
|
2021
Q4 | $10.1M | Buy |
74,920
+1,350
| +2% | +$183K | 0.82% | 29 |
|
|
2021
Q3 | $7.94M | Sell |
73,570
-875
| -1% | -$94.4K | 0.7% | 39 |
|
|
2021
Q2 | $8.39M | Buy |
74,445
+575
| +0.8% | +$64.8K | 0.75% | 35 |
|
|
2021
Q1 | $7.99M | Sell |
73,870
-3,255
| -4% | -$352K | 0.78% | 36 |
|
|
2020
Q4 | $8.26M | Buy |
+77,125
| New | +$8.26M | 0.83% | 32 |
|